Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Evaluation of Autosomal Recessive Polycystic Kidney Disease and Congenital Hepatic Fibrosis
This study is currently recruiting participants.
Study NCT00068224 Information provided by National Institutes of Health Clinical Center (CC)
First Received: September 10, 2003 Last Updated: August 24, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Congenital Hepatic Fibrosis
Caroli's Disease
Polycystic Kidney Disease
Joubert Syndrome
Cerebro-Oculo-Renal Syndromes
COACH Syndrome
Senior-Loken Syndrome
Dekaban-Arima Syndrome
Cogan Oculomotor Apraxia
Nephronophthisis
Bardet-Biedl Syndrome
Alstrom Syndrome
Oral-Facial-Digital Syndrome
Additional conditions recognized in this trial
Apraxias
Caroli Disease
Coma
Fibrosis
Kidney Diseases
Kidney Diseases, Cystic
Liver Cirrhosis
Oculocerebrorenal Syndrome
Orofaciodigital Syndromes
Polycystic Kidney Diseases
Polycystic Kidney, Autosomal Recessive
Syndrome
More general conditions related to this trial
Abnormalities, Multiple
Amino Acid Transport Disorders, Inborn
Bile Duct Diseases
Biliary Tract Diseases
Bone Diseases
Bone Diseases, Developmental
Brain Diseases
Brain Diseases, Metabolic
Brain Diseases, Metabolic, Inborn
Central Nervous System Diseases
Choledochal Cyst
Chromosome Disorders
Congenital Abnormalities
Consciousness Disorders
Craniofacial Abnormalities
Digestive System Abnormalities
Digestive System Diseases
Disease
Dysostoses
Genetic Diseases, Inborn
Genetic Diseases, X-Linked
Hypothalamic Diseases
Liver Diseases
Metabolic Diseases
Metabolism, Inborn Errors
Musculoskeletal Abnormalities
Musculoskeletal Diseases
Nervous System Diseases
Neurobehavioral Manifestations
Neurologic Manifestations
Pathologic Processes
Psychomotor Disorders
Renal Tubular Transport, Inborn Errors
Sex Chromosome Disorders
Signs and Symptoms
Unconsciousness
Urologic Diseases
Sponsors listed in this trial
National Human Genome Research Institute (NHGRI)
Back to top of Main Content